News and Announcements
Queensland Biochemist has Come Up With a Surprise Cure for Arthritis Pain
- Published April 09, 2015 11:25AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Source: The Courier Mail, by Jackie Sinnerton, 8th April 2015
A Queensland biochemist has come up with a surprise cure for arthritis pain- an ageold food flavour that has been used in wine since Roman times.
For 12 years, Greg Jardine has been devoted to researching wine antioxidants and has discovered that oak extract is a highly effective pain relief.
Professor Lindsay Brown, of Biomedical Sciences at the University of Southern Queensland, has tested the efficiency of the natural product and concluded that it outperforms aspirin and ibuprofen.
“We tested oak extract on rats with arthritis and found it to take effect very quickly,” he said.
“Their legs were swollen and stiff and unusable until we administered the product.”
Mr Jardine has discovered and now-patented biotechnology that extracts the oak antioxidants, allowing them to reach their full potential.
To read the full story, please click on the link below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
